Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 242 of 242 entries
View as:

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00630357 Org: User:
Start: 03/31/03 End: 07/31/04 Due: 07/31/05

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT00244387 Org: User:
Start: 03/31/04 End: 07/31/05 Due: 07/31/06

Facial Thermography Study of Levocetirizine Versus Cetirizine

Phase: N/A Priority: Normal
NCT ID: NCT00150761 Org: User:
Start: 07/31/04 End: 10/31/04 Due: 10/31/05

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00594165 Org: User:
Start: 06/30/02 End: 11/30/08 Due: 11/30/09

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01009242 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

Phase: N/A Priority: Normal
NCT ID: NCT00674362 Org: User:
Start: 06/30/08 End: 12/31/10 Due: 12/31/11

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Phase: N/A Priority: Normal
NCT ID: NCT00957944 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine

Phase: N/A Priority: Normal
NCT ID: NCT01504529 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02602860 Org: User:
Start: 11/30/15 End: 09/30/17 Due: 09/30/18

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Phase: N/A Priority: Normal
NCT ID: NCT00522379 Org: User:
Start: 07/31/07 End: 07/31/11 Due: 07/31/12

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00505687 Org: User:
Start: 02/28/05 End: 12/31/08 Due: 12/31/09

Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease

Phase: N/A Priority: Normal
NCT ID: NCT00624351 Org: User:
Start: 01/31/08 End: 08/31/09 Due: 08/31/10

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01262365 Org: User:
Start: 12/31/10 End: 05/31/15 Due: 05/31/16

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00599196 Org: User:
Start: 08/31/02 End: 12/31/08 Due: 12/31/09

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00699283 Org: User:
Start: 08/31/08 End: 03/31/10 Due: 03/31/11

Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT00308581 Org: User:
Start: 04/30/06 End: 04/30/08 Due: 04/30/09

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT01569464 Org: User:
Start: 03/31/12 End: 04/30/13 Due: 04/30/14